Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

NCT03166891 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chipscreen Biosciences, Ltd.